Mymichigan Medical Center Alpena
Mymichigan Medical Center Alpena was paid $21.24M by Medicaid between Jan 2018 and Dec 2024, across 334 billing codes. Its largest line is 99284, emergency room visit (serious) — 12% of everything it billed.
ALPENA, MI 49707
Next to other Rural Acute Care Hospital providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,924 | $2.22M | |
| 2019 | 100,288 | $2.45M | |
| 2020 | 83,699 | $2.23M | |
| 2021 | 106,324 | $3.09M | |
| 2022 | 131,103 | $3.65M | |
| 2023 | 139,971 | $4.14M | |
| 2024incomplete | 117,680 | $3.46M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 13,742 | 12,640 | $2.55M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 6,670 | 6,122 | $2.19M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.8% | 38,034 | 32,785 | $1.87M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.5% | 13,881 | 13,122 | $1.59M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 8,891 | 7,938 | $829K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.8% | 9,788 | 6,819 | $815K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 34,251 | 10,885 | $805K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.0% | 4,766 | 2,607 | $630K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.7% | 4,270 | 4,096 | $567K |
| J9271 | Injection, pembrolizumab, 1 mg | 2.6% | 87 | 67 | $544K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.3% | 26,356 | 8,699 | $478K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 6,632 | 6,405 | $444K |
322 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 11,500 | $341K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 1,537 | $322K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 12,474 | $310K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 3,078 | $299K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 8,239 | $292K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 3,142 | $278K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 8,528 | $249K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 1.0% | 325 | $217K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,975 | $208K |
| 94060 | <1% | 1,615 | $201K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,001 | $190K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 887 | $174K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,629 | $169K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,517 | $163K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 365 | $157K |
| 59025 | Fetal non-stress test | <1% | 1,698 | $151K |
| 97161 | <1% | 2,992 | $148K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,689 | $135K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,218 | $124K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 4,672 | $120K |
| G0378 | Hospital observation service, per hour | <1% | 1,824 | $120K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 372 | $120K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 640 | $112K |
| 80061 | Lipid panel | <1% | 6,013 | $110K |
| 76830 | Ultrasound, transvaginal | <1% | 1,918 | $109K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,059 | $106K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 989 | $105K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,548 | $103K |
| 96367 | <1% | 3,126 | $103K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 894 | $103K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,370 | $95K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 995 | $89K |
| 97162 | <1% | 1,646 | $88K | |
| 71250 | <1% | 1,755 | $88K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 767 | $86K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 183 | $86K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,095 | $81K |
| 36591 | <1% | 2,546 | $73K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 161 | $65K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,270 | $64K |
| 72110 | <1% | 1,624 | $60K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,290 | $59K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,327 | $49K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,490 | $45K |
| 76801 | <1% | 787 | $45K | |
| 96417 | <1% | 1,218 | $44K | |
| 76642 | <1% | 1,088 | $43K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,767 | $40K |
| 80053 | Comprehensive metabolic panel | <1% | 34,580 | $39K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 528 | $39K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 347 | $39K |
| 73030 | <1% | 1,911 | $39K | |
| 73564 | <1% | 1,189 | $37K | |
| 96415 | <1% | 928 | $36K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,207 | $35K |
| 73630 | <1% | 2,267 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40,210 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,608 | $33K |
| 76536 | <1% | 722 | $33K | |
| 97035 | <1% | 6,249 | $33K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,556 | $32K |
| 94726 | <1% | 1,730 | $32K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,492 | $31K |
| 86900 | <1% | 2,889 | $30K | |
| 73130 | <1% | 1,821 | $28K | |
| 73610 | <1% | 1,858 | $28K | |
| 93971 | <1% | 496 | $27K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 870 | $27K |
| 97163 | <1% | 391 | $21K | |
| 95811 | <1% | 56 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,622 | $21K |
| 74018 | <1% | 998 | $19K | |
| 72100 | <1% | 543 | $19K | |
| 72141 | <1% | 129 | $19K | |
| 73110 | <1% | 1,185 | $19K | |
| 97014 | <1% | 2,380 | $18K | |
| 73502 | <1% | 875 | $16K | |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 1,539 | $15K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 29 | $15K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 252 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,916 | $15K |
| 97165 | <1% | 300 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,549 | $14K |
| 77065 | Tomosynthesis, mammo | <1% | 315 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,552 | $13K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,118 | $12K |
| 82728 | <1% | 2,859 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,608 | $12K |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 739 | $11K |
| 71271 | <1% | 188 | $11K | |
| Q3014 | Telehealth originating site facility fee | <1% | 855 | $10K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,434 | $10K |
| 96416 | <1% | 64 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,153 | $10K |
| 82607 | <1% | 2,309 | $9K | |
| 93017 | <1% | 367 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,591 | $8K |
| 73562 | <1% | 297 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,209 | $8K |
| 96523 | <1% | 462 | $8K | |
| 20553 | <1% | 72 | $8K | |
| 87653 | <1% | 652 | $8K | |
| 90686 | <1% | 535 | $7K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 24 | $7K |
| 83550 | <1% | 2,489 | $7K | |
| 88142 | <1% | 753 | $7K | |
| 87081 | <1% | 4,377 | $7K | |
| 72050 | <1% | 136 | $6K | |
| 84439 | <1% | 2,941 | $6K | |
| 86803 | <1% | 1,180 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,979 | $6K |
| 76770 | <1% | 101 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 311 | $6K |
| 84702 | <1% | 1,517 | $6K | |
| 83540 | <1% | 2,673 | $6K | |
| 73221 | <1% | 43 | $5K | |
| 87340 | <1% | 1,397 | $5K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 453 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 4,616 | $5K |
| 96127 | <1% | 517 | $4K | |
| 83880 | <1% | 1,809 | $4K | |
| 36430 | <1% | 28 | $4K | |
| 93225 | <1% | 86 | $4K | |
| 85027 | <1% | 2,371 | $4K | |
| 97116 | <1% | 348 | $4K | |
| 83735 | <1% | 7,683 | $4K | |
| 73560 | <1% | 397 | $4K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 326 | $4K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 12 | $4K |
| 90677 | <1% | 14 | $3K | |
| 81001 | <1% | 16,463 | $3K | |
| 84481 | <1% | 810 | $3K | |
| 90678 | <1% | 12 | $3K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 68 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 220 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 55 | $3K |
| 73080 | <1% | 214 | $3K | |
| 84146 | <1% | 833 | $3K | |
| 20552 | <1% | 32 | $3K | |
| 86592 | <1% | 1,463 | $3K | |
| 73140 | <1% | 106 | $3K | |
| 90474 | <1% | 224 | $3K | |
| 86762 | <1% | 610 | $3K | |
| 97597 | <1% | 40 | $3K | |
| 87088 | <1% | 1,573 | $3K | |
| 87186 | <1% | 1,746 | $3K | |
| 86850 | <1% | 2,711 | $3K | |
| 90837 | Psychotherapy session, about an hour | <1% | 32 | $2K |
| 86140 | <1% | 3,567 | $2K | |
| 72131 | <1% | 54 | $2K | |
| 82746 | <1% | 588 | $2K | |
| 95806 | <1% | 28 | $2K | |
| 87070 | <1% | 895 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 40 | $2K |
| 72072 | <1% | 76 | $2K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 18 | $2K |
| 94618 | <1% | 140 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 137 | $2K |
| 80306 | <1% | 2,865 | $2K | |
| 82570 | <1% | 852 | $2K | |
| 88342 | <1% | 122 | $2K | |
| 96411 | <1% | 70 | $2K | |
| 93925 | <1% | 14 | $2K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 1,269 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 328 | $2K |
| 80076 | <1% | 499 | $1K | |
| 81025 | <1% | 7,049 | $1K | |
| 87276 | <1% | 4,459 | $1K | |
| 85610 | <1% | 4,853 | $1K | |
| 85652 | <1% | 2,531 | $1K | |
| 87077 | <1% | 870 | $1K | |
| 97012 | <1% | 192 | $1K | |
| 83615 | <1% | 1,064 | $1K | |
| 83970 | <1% | 79 | $1K | |
| 87275 | <1% | 4,459 | $1K | |
| 76882 | <1% | 24 | $1K | |
| 86703 | <1% | 209 | $1K | |
| 82951 | <1% | 178 | $1K | |
| 90480 | <1% | 27 | $1K | |
| 73090 | <1% | 86 | $929.44 | |
| 85730 | <1% | 2,355 | $921.67 | |
| 83690 | <1% | 5,268 | $901.30 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,199 | $866.22 |
| 77080 | <1% | 13 | $842.92 | |
| 76870 | <1% | 26 | $815.01 | |
| G0008 | Administration of influenza virus vaccine | <1% | 126 | $797.85 |
| 86901 | <1% | 2,891 | $728.91 | |
| 73523 | <1% | 15 | $713.31 | |
| 82043 | <1% | 315 | $679.32 | |
| 85018 | <1% | 778 | $630.73 | |
| 84156 | <1% | 525 | $626.97 | |
| 71101 | <1% | 37 | $624.18 | |
| 90656 | <1% | 38 | $589.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 29 | $580.02 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 39 | $572.44 |
| 82950 | <1% | 278 | $556.05 | |
| 85046 | <1% | 364 | $534.89 | |
| 87220 | <1% | 418 | $524.68 | |
| 0013A | <1% | 16 | $488.53 | |
| 87430 | <1% | 2,475 | $483.90 | |
| 87205 | <1% | 378 | $440.86 | |
| 87075 | <1% | 363 | $438.35 | |
| 88312 | <1% | 97 | $371.69 | |
| 74019 | <1% | 13 | $364.50 | |
| 83655 | <1% | 73 | $360.52 | |
| 85379 | <1% | 1,749 | $359.14 | |
| 86481 | <1% | 12 | $354.92 | |
| 84703 | <1% | 1,730 | $352.06 | |
| 87807 | <1% | 909 | $310.10 | |
| 84403 | <1% | 28 | $307.21 | |
| 94010 | <1% | 13 | $305.35 | |
| 82550 | <1% | 334 | $293.99 | |
| 81002 | <1% | 289 | $293.73 | |
| 72040 | <1% | 12 | $265.20 | |
| 82565 | <1% | 182 | $258.84 | |
| 87040 | <1% | 1,528 | $249.11 | |
| 70486 | <1% | 12 | $247.08 | |
| 73590 | <1% | 12 | $241.65 | |
| 87797 | <1% | 16 | $222.48 | |
| 97032 | <1% | 33 | $205.36 | |
| 84112 | <1% | 14 | $181.38 | |
| 86923 | <1% | 19 | $175.50 | |
| 12001 | <1% | 97 | $171.68 | |
| 80069 | <1% | 56 | $163.00 | |
| 73060 | <1% | 14 | $152.09 | |
| 83605 | <1% | 5,536 | $151.32 | |
| 84100 | <1% | 369 | $147.72 | |
| 90715 | <1% | 596 | $136.09 | |
| 85014 | <1% | 139 | $127.33 | |
| 87808 | <1% | 29 | $106.07 | |
| 84145 | <1% | 460 | $102.55 | |
| 70498 | <1% | 13 | $100.63 | |
| 86038 | <1% | 13 | $97.81 | |
| 80178 | <1% | 48 | $87.48 | |
| 82962 | <1% | 4,185 | $86.08 | |
| 88304 | <1% | 121 | $85.57 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 485 | $62.74 |
| 84484 | <1% | 5,804 | $46.62 | |
| 82150 | <1% | 14 | $41.11 | |
| 82140 | <1% | 32 | $38.36 | |
| 87420 | <1% | 13 | $36.64 | |
| 88313 | <1% | 267 | $36.25 | |
| 85045 | <1% | 27 | $34.48 | |
| 84460 | <1% | 16 | $33.73 | |
| 84450 | <1% | 16 | $32.96 | |
| 80164 | <1% | 14 | $28.57 | |
| 82378 | <1% | 23 | $20.74 | |
| 86308 | <1% | 28 | $12.84 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,582 | $1.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 1,043 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 11,286 | $0.00 |
| 99152 | 0% | 48 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 9,794 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 533 | $0.00 |
| 94729 | 0% | 1,722 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 3,286 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 92 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,577 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 1,380 | $0.00 |
| 94799 | 0% | 180 | $0.00 | |
| 90670 | 0% | 131 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 3,732 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 1,256 | $0.00 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 0% | 73 | $0.00 |
| 94664 | 0% | 624 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 832 | $0.00 |
| 90633 | 0% | 143 | $0.00 | |
| 90700 | 0% | 54 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 226 | $0.00 |
| 86318 | 0% | 352 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 246 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 249 | $0.00 |
| 93226 | 0% | 86 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 57 | $0.00 |
| 90681 | 0% | 128 | $0.00 | |
| J9190 | Injection, fluorouracil, 500 mg | 0% | 108 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 165 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 67 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 0% | 78 | $0.00 |
| J3489 | Injection, zoledronic acid, 1 mg | 0% | 14 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 23 | $0.00 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 0% | 14 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 16 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 82 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 17 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 7,593 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,467 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 5,103 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 594 | $0.00 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 0% | 1,123 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 4,648 | $0.00 |
| 96368 | 0% | 482 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 423 | $0.00 |
| 94760 | 0% | 550 | $0.00 | |
| 96376 | 0% | 2,644 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 8,165 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 5,138 | $0.00 |
| A9270 | Non-covered item or service | 0% | 1,852 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 916 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 1,858 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,734 | $0.00 |
| 90647 | 0% | 314 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 824 | $0.00 |
| J9045 | Injection, carboplatin, 50 mg | 0% | 154 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 418 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 303 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 25 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 244 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 162 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 1,205 | $0.00 |
| 80320 | 0% | 30 | $0.00 | |
| 90723 | 0% | 214 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 331 | $0.00 |
| 82803 | 0% | 75 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 56 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 202 | $0.00 |
| 88307 | 0% | 12 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 69 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 15 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 39 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.